Pirmitegravir is a potent and first-in-class inhibitor of allosteric integrase ( ALLINI ) that targets LEDGF/p75 binding site. Pirmitegravir displays picomolar IC 50 in human PBMCs with a >24,000 therapeutic index against HIV-1 . Pirmitegravir harbors outstanding anti-virus and safety properties.
Products | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HIV Integrase | Products > Signaling Pathways > HIV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.